Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Lucas M. Kimmig
Chuanhong Liao
Remzi Bag
机构：
[1] The University of Chicago Medicine,Section of Pulmonary and Critical Care Medicine
[2] The University of Chicago,Department of Public Health Sciences
[3] The University of Chicago,Biological Sciences Division
来源：
Lung | 2020年 / 198卷
关键词：
Pulmonary arterial hypertension; Prostacyclins; Prostanoids; Inhaled prostanoids; Transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 58
页数：5
相关论文
共 50 条
  • [31] Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?
    Michele Correale
    Deodata Montrone
    Riccardo Ieva
    Matteo Di Biase
    Natale Daniele Brunetti
    Clinical Research in Cardiology, 2013, 102 : 391 - 393
  • [32] Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?
    Correale, Michele
    Montrone, Deodata
    Ieva, Riccardo
    Di Biase, Matteo
    Brunetti, Natale Daniele
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (05) : 391 - 393
  • [33] Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension
    Ivy, D. Dunbar
    Feinstein, Jeffrey A.
    Yung, Delphine
    Mullen, Mary P.
    Kirkpatrick, Edward C.
    Hirsch, Russel
    Austin, Eric D.
    Fineman, Jeffrey
    Truong, Uyen
    Solum, Derek
    Deng, C. Q.
    Hopper, Rachel K.
    PULMONARY CIRCULATION, 2019, 9 (03)
  • [34] Oral treprostinil diethanolamine for pulmonary arterial hypertension
    Feldman, Jeremy
    Im, Yunhee
    Gill, Kirat
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 55 - 60
  • [35] Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension A Randomized Controlled Clinical Trial
    McLaughlin, Vallerie V.
    Benza, Raymond L.
    Rubin, Lewis J.
    Channick, Richard N.
    Voswinckel, Robert
    Tapson, Victor F.
    Robbins, Ivan M.
    Olschewski, Horst
    Rubenfire, Melvyn
    Seeger, Werner
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (18) : 1915 - 1922
  • [36] Experiences with treprostinil in the treatment of pulmonary arterial hypertension
    Stream, Amanda R.
    Bull, Todd M.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (05) : 269 - 276
  • [37] ORAL TREPROSTINIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    de Lartigue, J.
    DRUGS OF TODAY, 2014, 50 (08) : 557 - 565
  • [38] Oral treprostinil in the treatment of pulmonary arterial hypertension
    Feldman, Jeremy
    Habib, Naomi
    Radosevich, John
    Dutt, Mohan
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1661 - 1667
  • [39] Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Manes, Alessandra
    Jais, Xavier
    Pallazini, Massimiliano
    Humbert, Marc
    Presotto, Luis
    de Nillette, Louis
    Zaccardelli, Divid
    Davis, Gillian
    Jeff, Roger
    Simonneau, Gerald
    Galie, Naareno
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) : 1 - 5
  • [40] Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension
    Gomberg-Maitland, M
    Tapson, VF
    Benza, RL
    McLaughlin, VV
    Krichman, A
    Widlitz, AC
    Barst, RJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) : 1586 - 1589
12345